ContraFect Corp Valuation
| CFRXDelisted Stock | USD 1.18 0.08 6.35% |
Today, the firm appears to be overvalued. ContraFect Corp shows a prevailing Real Value of $1.12 per share. The current price of the firm is $1.18. Our model approximates the value of ContraFect Corp from analyzing the firm fundamentals such as Return On Equity of -6.09, shares owned by insiders of 0.65 %, and Current Valuation of (2.32 M) as well as examining its technical indicators and probability of bankruptcy.
Overvalued
Today
Please note that ContraFect Corp's price fluctuation is very steady at this time. Calculation of the real value of ContraFect Corp is based on 3 months time horizon. Increasing ContraFect Corp's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Since ContraFect Corp is currently traded on the exchange, buyers and sellers on that exchange determine the market value of ContraFect Stock. However, ContraFect Corp's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 1.18 | Real 1.12 | Hype 1.18 | Naive 1.3 |
The intrinsic value of ContraFect Corp's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence ContraFect Corp's stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of ContraFect Corp helps investors to forecast how ContraFect stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of ContraFect Corp more accurately as focusing exclusively on ContraFect Corp's fundamentals will not take into account other important factors: ContraFect Corp Total Value Analysis
ContraFect Corp is currently projected to have valuation of (2.32 M) with market capitalization of 535.24 K, debt of 2.88 M, and cash on hands of 27.3 M. The negative valuation of ContraFect Corp may imply that the market is not capable to price the future growth of the company or it is pricing it at zero value. It may also suggest that takeover valuation may not have captured all of the outstanding financial obligations of the company both on and off balance sheet. Investors should vigilantly validate all of the ContraFect Corp fundamentals.| Takeover Price | Market Cap | Debt Obligations | Cash |
(2.32 M) | 535.24 K | 2.88 M | 27.3 M |
ContraFect Corp Asset Utilization
One of the ways to look at asset utilization of ContraFect is to check how much profit was generated for every dollar of assets it reports. ContraFect Corp shows a negative utilization of assets of -1.17 percent, losing $0.0117 for each dollar of assets held by the firm. Inadequate asset utilization signifies that the company is being less effective with each dollar of assets it shows. Put another way, asset utilization of ContraFect Corp shows how discouraging it operates for each dollar spent on its assets.ContraFect Corp Ownership Allocation
Almost 93.22 percent of ContraFect Corp outstanding shares are held by general public with 0.65 (percent) owned by insiders and only 6.13 % by other corporate entities.ContraFect Corp Profitability Analysis
Net Loss for the year was (24.14 M) with loss before overhead, payroll, taxes, and interest of (1.61 M).About ContraFect Corp Valuation
Our relative valuation model uses a comparative analysis of ContraFect Corp. We calculate exposure to ContraFect Corp's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of ContraFect Corp's related companies.ContraFect Corporation, a clinical-stage biotechnology company, discovers and develops therapeutic protein and antibody products for the treatment of life-threatening and drug-resistant infectious diseases in the United States. ContraFect Corporation was incorporated in 2008 and is headquartered in Yonkers, New York. Contrafect operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 38 people.
ContraFect Corp Growth Indicators
Growth stocks usually refer to those companies expected to grow sales and earnings faster than the market average. Growth stocks typically don't pay dividends, often look expensive, and usually trading at a high P/E ratio. Nevertheless, such valuations could be relatively cheap if the company continues to grow, which will drive the share price up. However, since most investors are paying a high price for a growth stock, based on expectations, if those expectations are not fully realized, growth stocks can see dramatic declines.
| Common Stock Shares Outstanding | 521.4 K |
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area. You can also try the Risk-Return Analysis module to view associations between returns expected from investment and the risk you assume.
Other Consideration for investing in ContraFect Stock
If you are still planning to invest in ContraFect Corp check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the ContraFect Corp's history and understand the potential risks before investing.
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| Stocks Directory Find actively traded stocks across global markets | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets |